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Abstract. [Fe]-Hydrogenase catalyzes the reversible hydrogenation of a methenyl-
tetrahydromethanopterin substrate, which is an intermediate step during methanogenesis from 
CO2 and H2. The active site contains an iron-guanylylpyridinol (FeGP) cofactor, in which 
Fe
2+
 is coordinated by two CO ligands, as well as an acyl carbon atom and a pyridinyl 
nitrogen atom from a 3,4,5,6-substituted 2-pyridinol ligand. However, the mechanism of H2 
activation by [Fe]-hydrogenase is unclear. Here, we report reconstitution of [Fe]-hydrogenase 
from an apoenzyme using two FeGP cofactor mimics to create semi-synthetic enzymes. The 
small molecule mimics reproduce the ligand environment of the active site, but are inactive 
towards H2 binding and activation on their own. We show that reconstituting the enzyme 
using a mimic containing a 2-hydroxy pyridine group restores activity, whilst an analogous 
experiment with a 2-methoxy-pyridine complex was essentially inactive. These findings, 
together with DFT computations, support a mechanism in which the 2-hydroxy group is 
deprotonated before serving as an internal base for heterolytic H2 cleavage. 
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Table of content summary 
[Fe]-Hydrogenase has an iron-guanylylpyridinol cofactor and catalyzes the reversible 
hydrogenation of a methenyl-tetrahydromethanopterin. We reconstituted [Fe]-hydrogenase 
using cofactor mimics. The enzyme containing the mimic with a 2-hydroxy-pyridine group 
was active, while that containing a 2-methoxy-pyridine group was inactive. This result, 
together with DFT computations, supports a catalytic mechanism involving the deprotonated 
pyridinol hydroxy group as proton acceptor.  
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Future H2-utilizing technologies rely upon the development of new catalysts for activating H2. 
Robust, efficient, and inexpensive catalysts must be developed, for which nature provides 
intriguing design principles. In the microbial world, H2 is produced and utilized in energy 
metabolism, with the corresponding reactions being catalyzed by hydrogenases
1
. The three 
known types of hydrogenases commonly catalyze reversible cleavage of H2 to a proton and a 
hydride ion as an initial step. Two of the hydrogenases contain a dinuclear metal centre, either 
[NiFe] or [FeFe], and further catalyze the extraction of two electrons from the hydride
2,3
. The 
third hydrogenase, [Fe]-hydrogenase (Hmd), transfers the hydride ion to the methenyl-
tetrahydromethanopterin (methenyl-H4MPT
+
) substrate, which is an intermediate in the 
formation of methane from H2 and CO2 mediated by hydrogenotrophic methanogenic archaea 
(Fig. 1a)
4,5
.  
 
Figure 1 | Reaction catalyzed by [Fe]-hydrogenase and reconstitution of [Fe]-
hydrogenase with the model complexes of the iron-guanylylpyridinol (FeGP) cofactor. a, 
Reaction catalyzed by [Fe]-hydrogenase. b, Chemical structure of the FeGP cofactor. The 
groups lacking in the model complexes used in this work are highlighted in red. c, Stick 
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model (with protein surface model) of the FeGP cofactor covalently bound via cysteine 176  
to [Fe]-hydrogenase. Carbon, nitrogen, oxygen, phosphorous and sulphur atoms are depicted 
in gray, blue, red, orange, and yellow, respectively. The iron atom is shown as brown sphere. 
d, An overview of the strategy for reconstituting semi-synthetic [Fe]-hydrogenase from 
apoenzyme biologically produced in recombinant Escherichia coli and the chemically 
synthesized model complexes.  
 
 [Fe]-Hydrogenase contains a single iron in the iron-guanylylpyridinol (FeGP) 
cofactor at the active site (Fig. 1b and c). This cofactor can be isolated from the denatured 
native [Fe]-hydrogenase holoenzyme (protein with cofactor)
6,7
. Fully active [Fe]-hydrogenase 
can be reconstituted by mixing the [Fe]-hydrogenase apoenzyme (protein without cofactor) 
and the isolated FeGP cofactor
4,6,8
. The iron centre of the FeGP cofactor is coordinated to two 
cis-CO ligands, the acyl carbon and pyridinyl nitrogen atoms of a pyridinol ligand, and a 
cysteine sulphur atom (Fig. 1b). The Guanosine monophosphate (GMP) moiety of the FeGP 
cofactor significantly contributes to binding of the cofactor to the enzyme (Fig. 1c)
4,7,8
. 
Whereas the structure and properties of [Fe]-hydrogenase have been thoroughly studied, the 
mechanism of H2 activation remains speculative. A working hypothesis requires explanation 
of the following observations: (1) The extracted FeGP cofactor is inactive for H2 binding; (2) 
H2 can interact with the iron centre in the holoenzyme only after the binding of methenyl-
H4MPT
+
 to the enzyme, which converts the enzyme from an open to a closed 
conformation
9,10
.  
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Figure 2 | Structures of synthetic models of [Fe]-hydrogenase.  Complexes 1 and 2 both 
reproduce the first coordination sphere of the active site, but contain a methoxy and a hydroxy 
group at the second coordination sphere, respectively. Our strategy for reconstitution of semi-
synthetic [Fe]-hydrogenase is to substitute a labile ligand of a mimic with cysteine176 of the 
apoenzyme. Due to their higher stability and solubility, complexes 3 and 4 instead of 1 and 2 
were used for reconstitution. To dissolve 3 and 4 in aqueous solutions, these compounds were 
first dissolved in 99% methanol containing 1% acetic acid, in which they were probably 
converted to 3i and 4i, respectively.  
 
A number of complexes modelling the active site of [Fe]-hydrogenase have previously 
been synthesized 
11-17
. Recently, we prepared complexes 1 and 2, which reproduce the key 
features of the active site including the complete donor set, the unusual acylmethylpyridinyl 
ligation, and in the case of 2, the hydroxy group at the second coordination sphere (Fig. 
2).
12,13
 According to the infrared (IR) spectra, both model complexes have cis-CO ligands and 
similar electronic properties to the FeGP cofactor bound in [Fe]-hydrogenase. However, they 
neither bind nor activate H2, which is distinct from mimics of [NiFe]- and [FeFe]-
hydrogenases, some of which can heterolytically split H2 and catalyze H2 oxidation 
reactions.
18-21
 In the case of the isolated FeGP cofactor, its open-coordination site is blocked 
by 2-mercaptoethanol or acetate,
8,22
 which might inhibit the endogenous catalytic activity of 
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this cofactor. However, the inactivity of complexes 1 and 2 is not due to coordinative 
saturation, because one of the Fe-coordination sites is unoccupied. 
 The origin of the inactivity of 1 and 2 was probed by DFT computations. Several DFT 
studies
23-25
 suggest that [Fe]-hydrogenase coordinates and splits H2 heterolytically using the 
cysteine thiolate ligand as a proton acceptor to form a Fe hydride intermediate. A similar 
mechanism was used for computing model complexes (ref. 26-27 and Supplementary Fig. 1). 
It was found that binding of H2 is about 43 and 49 kJ/mol uphill for complexes 1 and 2, 
respectively, while the splitting of H2 has a further barrier of 66 and 53 kJ/mol.
26,27
 The 
overall barrier of more than 100 kJ/mol is consistent with the inactivity of 1 and 2 towards H2 
activation. On the other hand, the enzymatic reaction has a barrier of about 50 kJ/mol.
28,29
 
Given that the FeGP cofactor is only active when bound in the enzyme, we hypothesized that 
the inactivity of model complexes 1 and 2 arises from the lack of a protein environment. If 
these complexes could be placed in the same protein environment as the FeGP cofactor, they 
might become catalytically active. This reasoning was inspired by the recent reports of the 
reconstitution of highly active [FeFe]-hydrogenase from apoenzyme and less active synthetic 
models.
30-32
 Here, we report the successful incorporation of model complexes into the [Fe]-
hydrogenase apoenzyme, which leads to new insights into the mechanism.  
 
Results.  
Reconstitution using complex 3. In [Fe]-hydrogenase, the active site is covalently bound to 
the protein only through the cysteine 176 group. Our strategy for reconstitution is to substitute 
a labile ligand of a mimic with cysteine176 of the apoenzyme. Analogous ligand substitution 
chemistry was previously reported for the model complexes.
12,13
 Complexes 1 and 2 were 
prepared in this manner from precursors 4 and 3, respectively (Fig. 2). As 2 is the most 
faithful mimic, we started the reconstitution using complex 3. Water-insoluble 3 was 
dissolved in 99% methanol containing 1% acetic acid (methanol/acetic acid), in which 3 was 
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probably converted to intermediate 3i, as revealed by the IR spectrum after solvent 
evaporation (Fig.3). This IR spectrum resembled that of the FeGP cofactor extracted with 
acetic acid (Fig. 3)
22
, which shows the presence of only two CO ligands, indicating that 
dissolution in methanol/acetic acid leads to the loss of one CO ligand in 3. Both CO stretching 
frequencies of 3i were slightly higher than those of the FeGP cofactor extracted with acetic 
acid, which is consistent with the lack of electron-donating GMP and methyl groups in 3i. The 
IR spectrum of 3i is very similar to that of the isolated iron acetate complex formed upon the 
reaction of 3 with silver acetate 
13
. To reconstitute the holoenzyme, an excess amount of 
dissolved 3i was mixed with the [Fe]-hydrogenase apoenzyme from Methanocaldococcus 
jannaschii heterologously produced in Escherichia coli (Methods).  
 
 
 
Figure 3 | IR spectra of the model complexes and FeGP cofactor. Powder of 3 with 
potassium bromide (top), 3i dissolved in 1% acetic acid in methanol (middle), and the FeGP 
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cofactor extracted with acetic acid (bottom; spectrum from ref. 22). The spectra indicate that 
dissolution in methanol/acetic acid leads to the loss of one CO ligand in 3. 
 
The activity of [Fe]-hydrogenase reconstituted with 3i at 40 °C was photometrically measured 
for both the forward (reduction of methenyl-H4MPT
+
 with H2) and the reverse reactions (H2 
production from methylene-H4MPT) (reaction scheme shown in Fig. 1a)(Methods)
33
. The 
absorbance at 336 nm of methenyl-H4MPT
+
 decreased and increased in the forward and 
reverse reactions, respectively (Fig. 4a and b). With the apoenzyme or 3i (dissolved in 
methanol/acetic acid) alone, the spectra of methenyl-H4MPT
+
 and methylene-H4MPT were 
unchanged (Fig. 4c and d). The production of H2 from methylene-H4MPT in the reverse 
reaction was detected by gas chromatography (Fig. 4e); the specific activity of H2 formation 
was in agreement with that determined in the photometric assay. The specific activities of the 
reconstituted enzyme in the forward and reverse reactions under standard assay conditions 
were 3 U/mg and 2 U/mg, respectively. The corresponding turnover frequencies are 2 s
-1
 and 
1 s
-1
, respectively. These rates are very high compared to synthetic hydrogenation 
catalysts
34,35
, which have turnover frequencies typically between 10
-3
 to 0.1 s
-1
,
 
and only in 
exceptional cases, have turnover frequencies on the order of 1 s
-1
. The specific activities of the 
reconstituted enzymes are approximately 1% of those of the native enzyme. From the 
Arrhenius equation, a 100-fold decrease in the reaction rate corresponds to an increase of only 
~12 kJ/mol in the activation energy, whereas the activation energy of the [Fe]-hydrogenase 
catalyzed reaction is ~50 kJ/mol
28,29
.  
The apparent Km values for methenyl- and methylene-H4MPT are similar to that of the native 
enzyme (Supplementary Fig. 2)
29
. The apparent Km for H2 was substantially higher than that 
of the native enzyme (Supplementary Fig. 3). The optimal pH for the H2-producing activity 
was lower than that of the native enzyme (Supplementary Fig. 4). The reconstituted enzyme 
was inhibited by p-toluenesulfonylmethyl isocyanide, a strong specific inhibitor of [Fe]-
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hydrogenase
36
, but the inhibition constant (Ki = 30 nM) was higher than that of the native 
enzyme (Ki = 1 nM). The enzyme reconstituted in the presence of 2 mM GMP exhibited 
approximately a two-fold higher specific activity than in the absence of GMP (Supplementary 
Fig. 5a). The addition of GMP after incorporation of 3i also increased the activity roughly 
two-fold. The addition of other nucleoside monophosphates (i.e. AMP, CMP and UMP) into 
the reconstitution solutions did not affect the activity of the reconstituted enzyme. Maximal 
reconstitution of the active holoenzyme took 1 h (Supplementary Fig. 6). Kinetic profiles of 
the complex incorporation were similar in the absence and presence of GMP.  
The stoichiometry of the complexes was determined using peak area ratios of the CO 
and protein-amide II bands in the IR spectra of the reconstituted enzymes (Supplementary 
Table 1). These data indicated that the occupancy of 3i in the reconstituted enzymes with 
GMP was approximately 50%. Based on the stoichiometric data, the specific activity of the 
reconstituted [Fe]-hydrogenase should be two times higher than described above. 
 
  
Figure 4 | Activity of the [Fe]-hydrogenase holoenzyme reconstituted with model 
compound 3i. a, Consumption and b, formation of methenyl-H4MPT
+
 were detected 
(direction of the reactions is indicated by arrows); the changes of absorbance at 336 nm of the 
consumption and formation reactions were plotted in c and d, respectively. In the absence of 
3i (blue), the apoenzyme (red), and both 3i and the apoenzyme (green) in the reconstitution 
mixture, no activity was detected (c and d) (Methods). The spectral changes were measured at 
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least three times. e, Production of H2 in the assay (Methods). Error bars determined by the 
standard deviation of three measurements.  
 
The IR spectrum of the reconstituted [Fe]-hydrogenase with 3i in the absence of GMP 
(Fig. 5a) (Methods) shows that the peak positions of the dominant bands at ~ 2020 cm
-1
 and 
1945 cm
-1
 are similar to those of the [Fe]-hydrogenase holoenzyme reconstituted with the 
FeGP cofactor (2011 cm
-1
 and 1944 cm
-1
)
8,36,37
. This suggests incorporation of 3i into the 
active site. The IR spectrum also exhibits a number of minor peaks, indicative of a certain 
amount of 3i that was unspecifically bound (Supplementary Table 1). When the [Fe]-
hydrogenase was reconstituted in the presence of 2 mM GMP, the number of minor peaks in 
the IR spectrum recorded in the absence of GMP were significantly reduced, and the spectrum 
exhibited two major peaks at 2016 and 1944 cm
-1
. This spectrum resembles that of native 
[Fe]-hydrogenase, although minor peaks at 2073 and 2035 cm
-1
 remained in the former (Fig. 
5a). Thus, the presence of GMP apparently leads to improved binding of model complex with 
the apoenzyme.  
In the native holoenzyme the iron is coordinated by cysteine 176. A C176A mutant 
apoenzyme was then used for reconstitution with 3i. The IR spectrum in the absence of GMP 
exhibits many peaks in the region where CO vibrations occur (Fig. 5b). Adding GMP did not 
significantly reduce the number of CO bands, or convert the spectrum into two major peaks 
(Fig. 5b), as was the case for reconstitution using the native holoenzyme.  In all cases, the 
ratio of 3i to protein was around two-fold (Supplementary Table 1). These data suggest that 3i 
was either unspecifically bound to the C176A mutant apoenzyme, or was bound in the active 
site but with a different coordination environment than that of the native enzyme due to the 
absence of the Cys176 thiolate ligand. The reconstituted C176A enzymes with 3i in the 
presence and absence of GMP showed no enzyme activity. This result is consistent with the 
previous finding that the C176A enzyme reconstituted with the FeGP cofactor is inactive.
38
 In 
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the latter case, the FeGP cofactor is coordinated to an exogenous dithiothreitol ligand, which 
is required to stabilize the cofactor. In the current case, the iron centre is probably coordinated 
to an acetate ligand present in the reaction medium. Thus, cysteine 176 is important for the 
correct binding of the FeGP cofactor or 3i in the active site, which is required for activity.   
     
Figure 5 | IR spectra of the [Fe]-hydrogenases reconstituted with 3i and 4i. a, Wild-type 
[Fe]-hydrogenase reconstituted with  3i in the absence (top) and presence (middle) of 2 mM 
GMP, and [Fe]-hydrogenase reconstituted with the FeGP cofactor (bottom). b, C176A [Fe]-
13 
 
hydrogenase reconstituted with 3i in the absence (top) and presence (middle) of 2 mM GMP, 
and the C176A [Fe]-hydrogenase reconstituted with the FeGP cofactor (bottom). c, Powder of 
4 with potassium bromide (top), 4i dissolved in 1% acetic acid in methanol (middle), and the 
FeGP cofactor extracted with acetic acid (bottom; spectrum from ref. 22). d, Wild-type [Fe]-
hydrogenase reconstituted with  4i in the absence (top) and presence (middle) of 2 mM GMP, 
and wild-type [Fe]-hydrogenase reconstituted with the FeGP cofactor (bottom). The IR 
spectra suggest successful incorporation of 3i and 4i in the apoenzyme of [Fe]-hydrogenase. 
The spectra also suggest that the presence of GMP leads to improved binding of 3i to the 
apoenzyme, and cysteine 176 is important for the correct binding.  
 
Reconstitution using complex 4. Recent studies suggest that the 2-hydroxy group of the 
pyridinol ring of the FeGP cofactor might be important for H2 activation
39,40
. To directly test 
the importance of the hydroxy group, we used compound 4, which has a 2-methoxy group at 
the pyridine ring for the reconstitution of [Fe]-hydrogenase (Fig. 2). When dissolved in 
methanol/acetic acid, compound 4 was partially converted to 4i, revealed by an IR spectrum 
with two broad CO bands at 2019 and 1967 cm
-1
 (Fig. 5c).  
Likely owing to the high hydrophobicity of 4i, an excess amount of this complex 
unspecifically binds to the [Fe]-hydrogenase apoenzyme under the reconstitution conditions 
used for 3i. To alleviate this unspecific binding, 0.5 mM of 4i was mixed with equimolar 
apoenzyme in the reconstitution mixture. The reconstitution solution was incubated on ice for 
1 hour and the unbound compound was then removed by ultrafiltration. The IR spectrum of 
the reconstituted [Fe]-hydrogense revealed two major CO peaks at 2013 and 1953 cm
-1
, 
associated with weak shoulder peaks at 2025 and 1970 cm
-1
, respectively (Fig. 5d). The 
positions of the two major peaks are similar to those of [Fe]-hydrogenase reconstituted with 
the FeGP cofactor and 3i (Fig. 5a). The positions of the shoulder peaks are similar to those of 
unbound 4i (Fig. 5c), indicating that a small amount of 4i was unspecifically bound to the 
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protein. Addition of GMP to the reconstitution solution decreased the relative intensities of 
the CO bands at 2025 and 1970 cm
-1
, suggesting a decrease in the unspecific binding of 4i. 
The activity of the 4i-reconstituted protein was less than 0.01 U/mg in both catalytic 
reactions, which is at the detection limit of the enzyme assay. This finding indicates that 2-
hydroxy group is crucial for reconstitution of the active enzyme.  
 
DFT computations. The electronic properties of model complexes containing the 2-OH and 
2-OMe groups are similar according to their IR spectra.
12,13
 DFT computations also indicate 
that the energy barriers for H2 binding and cleavage are similar for complexes 1 and 2, if 
heterolytic H2 cleavage involving the thiolate ligand is considered (Supplementary Fig. 1). 
Thus, the dramatic difference in the activity of semisynthetic enzymes incorporating 3i and 4i 
points to a different mechanism. Unlike the methoxy group, the hydroxy group can be 
deprotonated to form a strong base. In [FeFe]-hydrogenase, the amine nitrogen in the 
azadithiolate bridge acts as an internal base for heterolytic H2 cleavage.
30
 It is possible that the 
OH group in the FeGP cofactor, as well as in 3i, is deprotonated and functions similarly to the 
amine base in [FeFe]-hydrogenase. This possibility was previously suggested by theoretical 
studies.
23,40
 To further explain experimental observations, we employed DFT computations to 
compare two mechanisms using complex 5 in which the tert-butyl thiolate group of 2 is 
replaced by a smaller methyl thiolate ligand, which is a better mimic of the natural cysteine 
ligand (Fig. 6). One mechanism involves thiolate as the proton acceptor, while the other 
mechanism involves the deprotonated OH group as the proton acceptor. Considerations of 
various mechanistic pathways are described in Supplementary Figs. 7 and 8 and 
Supplementary Tables 2-4. Because substrate binding triggers H2 activation in [Fe]-
hydrogenase, the mechanisms involving substrate binding as the first step are most relevant 
(Fig. 6).  
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Figure 6 | Lowest energy reaction pathways for the catalytic cycles involving model 
complexes 5 and 6. Computations at the B3LYP-dDsC/TZ2P//M06/def2-SVP level in 
implicit THF solvent (COSMO-RS)]. MPT
+
 is a truncated model of methenyl-H4MPT
+
 and 
was used as the hydride acceptor; 1-methylimiazole was used as the external proton acceptor. 
Compound numbering corresponds to the structures in Supplementary Fig. 7 and 8. The 
results indicate that the key steps in the catalysis are the deprotonation of 2-hydroxy group of 
the pyridinol ligand (5A to 6A) and the heterolytic H2 activation using the 2-O
-
 group as an 
intramolecular proton acceptor.  
 
For complex 5, the lowest energy reaction pathway proceeds via MPT
+
 association (5A 
 5G), H2 association (5G  5H) and activation (5H  5TS3  5D), followed by proton 
removal utilizing 1-methylimidazole as an acceptor (5D  5E). At this point a Fe-hydride 
species is formed, which can transfer the hydride to MPT
+
 (5E  5TS2  5F) with a small 
barrier. The catalytic cycle is closed via the dissociation of HMPT to reform the starting 
catalyst (5F  5A). The overall barrier of 137 kJ/mol is too high for the reaction to take place 
under biological conditions. On the other hand, deprotonation of the 2-OH group in 5 changes 
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the energy landscape dramatically. Deprotonation of 5 by 1-methylimidazole to form 6 is 15 
kJ/mol uphill, and MPT
+
 association (6A  6G) now costs only 8 kJ/mol. The significantly 
lower energy cost for MPT
+
 binding on 6 compared to 5 might be attributed to an electrostatic 
interaction of the electronegative 2-O
-
 group and the electropositive substrate, as suggested in 
a recent multi-scale modelling study.
40
  H2 binding costs an additional 33 kJ/mol (6G  6H). 
Remarkably, heterolytic H2 splitting utilizing the 2-O
-
 group as the internal base is extremely 
facile (6H  6TS3  6D), with a transition state barrier of only 2 kJ/mol. When 6D is 
deprotonated using 1-methylimidazole the hydride ligand spontaneously migrates to MPT
+
 to 
form HMPT in an exergonic process (6D  6F). Species analogous to 5E and 5TS2 do not exist 
on the potential energy surface, consistent with the barrier-less hydride transfer. Finally, the 
original deprotonated catalyst can be reformed following dissociation of HMPT (6F  6A). 
The highest point of the potential energy surface is 59 kJ/mol. Given the accuracy of DFT, 
this calculated energy barrier is in good agreement with the activity of the semisynthetic 
enzyme reconstituted from 3i. Therefore, DFT computations clearly show that deprotonation 
of the 2-hydroxy group leads to an experimentally feasible catalytic cycle.  
 
Cleavage of GMP.  To test the effect of the GMP moiety on the function of the FeGP 
cofactor, the native cofactor was anoxically digested by phosphodiesterase I from Crotalus 
adamanteus venom at pH 8.9 in the presence of 1 mM 2-mercaptoethanol. Digestion of the 
FeGP cofactor was traced by UV-Vis measurements (Supplementary Fig. 9). The spectral 
change completed within 10 min in this assay, indicating that the FeGP cofactor was 
completely digested within 10 min under these reaction conditions. To verify the hydrolytic 
cleavage of the GMP moiety, the digested sample was decomposed with light and the masses 
of the decomposition products were determined by Matrix-assisted laser desorption/ionization 
mass spectrometry. In the mass spectrum, the peaks of the predicted decomposed product, 6-
carboxymethyl-3,5-dimethyl-2-pyridone (m/z = 198), but not the non-digested 
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guanylylpyridinol [(6-carboxymethyl-3,5-dimethyl-4-hydroxy-2-pyridone-4-yl)-(5’-guanosyl) 
phosphate (m/z = 543)], were observed (Supplementary Fig. 10). This finding confirmed the 
cleavage of the phosphodiester linkage of the FeGP cofactor in the phosphodiesterase 
reaction. The [Fe]-hydrogenase reconstituted with this digested cofactor has a specific activity 
of 0.8  0.2 U/mg for the reverse reaction. IR analysis showed that occupancy of the enzyme-
digested cofactor in the protein was approximately 4% (Supplementary Fig. 11 and 
Supplementary Table 1). Assuming that the enzyme-digested cofactor is solely responsible for 
the activity (although the possibility of a trace amount of native FeGP cofactor in the enzyme 
is hard to rule out), the specific activity of the GMP-less native enzyme is 20 U/mg, which is 
a 10-fold decrease compared to the wild enzyme, but a 5-fold increase relative to the enzyme 
reconstituted with 3i. This result is consistent with the significant roles of the GMP and the 
two methyl groups of the guanylylpyridinol ligand.      
 
Discussion. 
We successfully constructed an active [Fe]-hydrogenase from an apoenzyme and 3i. This 
“semisynthetic” enzyme exhibited a higher turnover frequency than most known synthetic 
hydrogenation catalysts.
34,35
 The iron centre in this reconstituted enzyme is most probably 
coordinated in the same manner as the iron ion in native [Fe]-hydrogenase, namely by one 
cysteine sulphur atom, two CO ligands, and the acyl carbon and pyridnyl nitrogen atoms of 
the 2-hydroxypyridinol ligand, as indicated by the IR spectrum (Fig. 5a). This ligand 
environment is nearly identical to that of complex 2. Until now, all model complexes, 
including 1-4, were inactive for H2 activation despite having similar geometric and electronic 
structures to the active site of [Fe]-hydrogenase. The activity of this semisynthetic enzyme 
confirms the essential role of the protein environment for H2 activation. The reconstituted 
[Fe]-hydrogenase with the 2-methoxy complex 4i was inactive even with the complex being 
incorporated into the apoenzyme. This finding highlights the crucial role of the 2-hydroxy 
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group for the catalytic activity of [Fe]-hydrogenase. It is possible that the 2-hydroxy group 
serves to correctly position the cofactor in the protein. The crystal structure of [Fe]-
hydrogenase shows that the Fe pyridinol complex is fixed onto the protein by a covalent bond 
through the cysteine-sulphur atom, a hydrogen bond through the acyl-oxygen atom, and 
multiple hydrophobic interactions through one of the CO ligands; the 2-hydroxy group 
appears to have no contact with protein (Supplementary Fig. 12) 
4,8,10
. Therefore, the 
possibility of substantially different orientations of 3i and 4i in the reconstituted enzyme is 
unlikely. To account for the significantly different activity of the two semisynthetic enzymes, 
an alternative explanation is proposed, in which the hydroxy group is deprotonated and then 
functions as an internal base for heterolytic cleavage. DFT computations show this 
mechanism possesses a much lower activation barrier than the alternative mechanism in 
which the cysteine thiolate ligand serves as a proton acceptor. While some elements of the 
new mechanism were previously proposed,
23,40
 the work described here provides the first 
experimental validation of this mechanism.    
 Substrate binding appears to be the trigger event for the function of [Fe]-hydrogenase. 
Without methenyl-H4MPT
+
, [Fe]-hydrogenase retains an open form and does not bind or 
activate H2. Upon binding of methenyl-H4MPT
+
, [Fe]-hydrogenase adopts the closed form 
where H2 binding and activation occur. Until now, it has been unclear how substrate binding 
and the resulting conformational change modify the reactivity of the active site. This study 
suggests that deprotonation of the 2-OH group is a key step for catalysis. Thus, we propose 
that [Fe]-hydrogenase controls its activity in the two conformations by allowing deprotonation 
only in the closed conformation. In the closed form, the 2-OH group could be located near the 
methenyl-H4MPT
+
 substrate in the active site pocket, which might change the pK value of this 
group
10
 . Alternatively, as suggested by Reiher and co-workers in their DFT computations, the 
His14 group, which is located near the 2-hydroxy group, might play a role in modulating the 
pK of the 2-hydoxy moiety.
40
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 The lower catalytic activity of the semisynthetic [Fe]-hydrogenase relative to the 
native enzyme may be due to the differences in 2-pyridinol ring substitution. The 3- and 5-
methyl groups in the native cofactor will affect the electronic properties of the pyridinol 
nitrogen via their electron-donating effect. The 4-phosphate ester group will also affect the pK 
of the pyridinol nitrogen and could additionally contribute to cofactor binding
4
. The 
guanosine moiety of the 4-substituent contributes to the correct binding of the cofactor to the 
protein through an induced fit, consistent with the finding that in the presence of GMP the IR 
spectrum of the bound mimic sharpened (Fig. 5a)  and the catalytic activity increased 
(Supplementary Fig. 5). The importance of the GMP moiety for the reconstitution of the 
active enzyme was also indicated by the enzymatic digestion study described above.  Despite 
these differences, the activation energy for the semisynthetic [Fe]-hydrogenase reported here 
is only ~12 kJ/mol higher than the optimized native enzyme.  
 The reconstitution method developed here is general and can be applied to incorporate 
different synthetic mimics into the apoenzyme of [Fe]-hydrogenase. In the future, it may be 
possible to test, one by one, the contributions of the 3- and 5- methyl groups as well as of the 
4-phosphoester group on the binding of iron-active-site and the subsequent activity. It may 
also be possible to test the contribution of the two CO ligands by synthesizing mimics with 
only one CO or with one CO and one cyanide in different configurations. The contribution of 
the sulphur ligand and of the second coordination sphere is accessible using mutated 
apoenzyme in the reconstitution experiments.  These studies will hopefully contribute to our 
understanding of the necessary primary and secondary coordination environments for iron to 
activate H2, a question of considerable applied interest.  
 Chemical modification strategies such as those described here are presently used to 
understand the structure and function relationship of the [FeFe] centre in [FeFe]-
hydrogenases
30-32
. Learning how iron in [Fe]-hydrogenase functions may even contribute to 
our understanding of the role of iron in the [FeFe] centre of [FeFe]-hydrogenases and the 
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[NiFe] centre of [NiFe]-hydrogenases, in which the iron is also decorated with CO and other 
unusual ligands. 
 
 
 
METHODS 
Reconstitution of the [Fe]-hydrogenase holoenzyme. The model complex 3 (see Fig. 2 in 
the main text) was dissolved in methanol containing 1% acetic acid. For reconstitution of the 
[Fe]-hydrogenase holoenzyme, 0.4 ml of 10 mM 3i solution was added anoxically into a 7.6 
ml solution of 100 mM sodium acetate (pH 5.6), 0.02 mM apoenzyme, and 2 mM GMP (final 
concentrations) on ice and quickly and thoroughly mixed; the final concentrations of 3i and 
the apoenzyme were 0.5 mM and 0.02 mM (25:1 ratio), respectively. Five % methanol 
contained in the reconstitution solution does not affect the stability of the apoenzymes. After 
incubation on ice for at least 1 hour, the reconstitution mixture was used for the catalytic 
activity assays. The reconstituted enzyme was unstable at room temperature and was 
completely inactivated after overnight incubation if not kept cool; activity of the enzyme 
reconstituted with the FeGP cofactor stays stable at room temperature in the same period. The 
instability of the enzyme reconstituted with the model complex could be attributed to the 
instability of the complex in relatively hydrophilic protein environment, probably because of 
the less hydrophilic character of the complex due to the absence of the GMP moiety. The 
enzyme reconstituted with 3i was inactivated by light like the enzyme reconstituted with the 
FeGP cofactor. Therefore, the reconstituted enzyme solution was kept on ice during the 
experiments and used within several hours under dark conditions. For long-term storage, the 
reconstituted enzyme was shock-frozen in liquid nitrogen and stored at –75 °C. For IR 
spectroscopy, the reconstituted enzyme solution was concentrated to ~50 µl in a Millipore 
centrifuge concentrator with a 30-kDa cut-off ultra-filter. Then, the concentrated solution was 
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diluted more than ten-fold with anoxic water containing 2 mM GMP, and then concentrated 
again to 2–3 mM reconstituted enzyme with 2mM GMP. The sample without GMP was 
diluted with anoxic water in the absence of GMP and then concentrated. In the case of 
reconstitution in the absence of GMP, GMP was omitted throughout the experiments.  For 
reconstitution with 4i, 6.0 µl of 10 mM 4i solution was added anoxically into a 0.25 ml 
solution containing 100 mM sodium acetate (pH 5.6), 0.5 mM apoenzyme, and 2 mM GMP 
(final concentrations) on ice and quickly and thoroughly mixed; the final concentrations of 4i 
and the apoenzyme were 0.5 mM. After incubation on ice for at least 1 hour, the 
reconstitution mixture was used for the catalytic activity assays. For IR spectroscopy, the 
reconstituted enzyme solution was concentrated to ~20 µl in a Millipore centrifuge 
concentrator with a 30-kDa cut-off ultra-filter. Then, the concentrated solution was diluted 
more than ten-fold with anoxic water containing 2 mM GMP, and then concentrated again to 
2–3 mM reconstituted enzyme with 2mM GMP. In the case of reconstitution in the absence of 
GMP, GMP was omitted throughout the experiments. Concentrated samples were stored in a 
Cryogenic Liquid Nitrogen Dry Shipper (Taylor-Wharton).  
IR spectroscopy. All IR spectra were obtained with an FTIR spectrometer (Bruker, Vertex 
70V) in an attenuated total reflection (ATR) optical configuration with Si prism of 45° 
incident angle and 2 active reflection (Smith Detection, DuraSamplIR IITM). Spectra were 
obtained with a resolution of 4 cm
-1
. Five µl of the sample solutions were dropped on the 
effective area of a Si prism (3mm diameter) and concentrated by slowly evaporating solvent 
under mild flow of Ar gas. Hydration condition of the sample is estimated by relative 
intensities of water band (OH stretching mode) at around 3500 cm
-1
 against the amide II band 
of the protein at around 1550 cm
-1
. Of the spectra that had been measured successively during 
the concentration process, we selected a spectrum of mildly hydrated sample that provided 
enough intensity to analyze the cofactor bands. A baseline correction had been made on the 
selected spectrum to eliminate contributions from the water overtone band around 2000 cm
-1
. 
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Typically 512 spectra were co-added to obtain a sufficient signal-to-noise ratio. Measurement 
was handled under dark by covering the spectrometer with a blackout fabric in order to avoid 
light induced decomposition of the sample. 
 
Computational Methods. Molecular structures were first optimized at the M06
41,42
/def2-SVP 
theoretical level using the SMD polarizable continuum model
43
 for THF and the “Ultrafine” 
grid as implemented in Gaussian09.
44
 Unscaled free energy correction was obtained from 
frequency computations on optimized geometries, which confirmed that all structures were 
either minima (zero imaginary frequencies) or transition states (one imaginary frequency) on 
the potential energy surface. Refined energy estimates, employing a density-dependent 
dispersion correction
45
 appended to the B3LYP functional
46,47
 (B3LYP-dDsC) to more 
accurately describe long-range dispersion interactions, were obtained via single point 
computations using the TZ2P slater-type orbital basis set in ADF.
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